Nicholas Groombridge is co-chair of the patent litigation and counseling practice at Paul, Weiss, Rifkind, Wharton & Garrison.
Over the past 17 years, Groombridge has been extensively involved in all aspects of patent litigation, including trials (both bench and jury). He has been lead counsel in numerous patent infringement actions in federal district courts, and has successfully argued cases in the Court of Appeals for the Federal Circuit.
Groombridge has litigated patents in a wide variety of technical areas with particular focus on pharmaceuticals and biotechnology. In particular, he has handled numerous litigation and other matters involving assays, biologics, bioinformatics, diagnostics, drugs (both prescription and over-the-counter), drug delivery systems, and research tools for such clients as Applied BioSystems, Bausch & Lomb, Celera, GlaxoSmithKline, Monsanto, Novartis, Pfizer, Schering, Takeda and Yeda Research & Development.
Most recently, he was named one of the Lawdragon’s 500 U.S. leading litigators as well as a “New York Super Lawyer” in the intellectual property field.
Groombridge received his J.D. from the London School of Economics and Political Science in 1981.